Ophthalmology, Glaucoma Specialist · Syracuse, NY
NPI
1538362058
Since 2007
Specialty
Ophthalmology, Glaucoma Specialist
Code 207WX0009X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
5792 Widewaters Pkwy Ste 101
Syracuse, NY, 13214
Phone (315) 422-4412
Groups this clinician bills Medicare through
Medicare paid, 2024
$252K
5,080 services
Medicare patients, 2024
724
Average age 79
Drug cost, 2024
$1.6M
8,127 prescriptions
Company payments, 2025
$550
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony F Devincentis III was code 92133 (computerized ophthalmic imaging), 1,162 times for 657 patients. In total Anthony F Devincentis III billed 5,080 services in 32 codes, and Medicare paid $252K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-04.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92133 Computerized Ophthalmic Imaging | Office | 1,162 | 657 | $21.88 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,052 | 589 | $40.41 | $43K |
| 99213 Office E&M - Established | Office | 1,041 | 601 | $60.29 | $63K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 684 | 528 | $12.41 | $8,485 |
| 92014 Ophthalmological E&M | Office | 309 | 293 | $81.94 | $25K |
| 99214 Office E&M - Established | Office | 285 | 238 | $93.72 | $27K |
| 92020 Ophthalmological E&M | Office | 171 | 157 | $18.36 | $3,140 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 86 | 50 | $167.98 | $14K |
| 92134 Computerized Ophthalmic Imaging | Office | 59 | 37 | $26.19 | $1,545 |
| 76514 Ultrasound - Nonspecific | Office | 54 | 54 | $7.32 | $395 |
| 92004 Ophthalmological E&M | Office | 45 | 45 | $98.28 | $4,422 |
| 92250 Angiography | Office | 25 | 25 | $20.49 | $512 |
| 66180 Fluid Flow and Drainage of Eye (Any Method) | Facility | 18 | 15 | $828.30 | $15K |
| 66821 Cataract Surgery | Office | 16 | 14 | $239.11 | $3,826 |
By year: 2022 $267K for 4,832 services; 2023 $246K for 4,722 services; 2024 $252K for 5,080 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony F Devincentis III prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 1,249 prescriptions and refills. In total Anthony F Devincentis III wrote 8,127 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,249 | 3,250 | 382 | $27K |
| Brimonidine Tartrate Generic | 752 | 1,846 | 235 | $82K |
| Lumigan Bimatoprost | 713 | 1,610 | 214 | $425K |
| Latanoprost Generic | 590 | 1,473 | 208 | $7,733 |
| Travoprost Generic | 528 | 1,235 | 167 | $135K |
| Timolol Maleate Generic | 489 | 1,220 | 161 | $28K |
| Prednisolone Acetate Generic | 461 | 1,148 | 178 | $24K |
| Brinzolamide Generic | 296 | 709 | 99 | $80K |
| Dorzolamide Hcl Generic | 288 | 692 | 99 | $7,733 |
| Pilocarpine Hcl Generic | 284 | 643 | 93 | $23K |
| Bimatoprost Generic | 238 | 544 | 74 | $40K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 209 | 524 | 74 | $50K |
| Rhopressa Netarsudil Mesylate | 195 | 435 | 69 | $133K |
| Bromfenac Sodium Generic | 160 | 275 | 61 | $33K |
| Combigan Brimonidine Tartrate/Timolol | 146 | 335 | 42 | $65K |
Brand drugs: 2,962 claims; generic drugs: 5,165 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony F Devincentis III $550 ($550 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alcon Vision LLC with $233.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.